Related Experiment Video
Updated: Jul 21, 2026
07:48
Staining Protocols for Human Pancreatic Islets
Published on: May 23, 2012
Relationships among age, proinsulin conversion, and beta-cell function in nondiabetic humans
Andreas Fritsche1, Alexander Madaus, Norbert Stefan
1Medizinische Klinik, Abteilung für Endokrinologie, Stoffwechsel und Pathobiochemie, Eberhard-Karls-Universität, Tübingen, Germany.
Diabetes
|January 30, 2002
Summary
Aging impairs beta-cell function and proinsulin conversion to insulin. This age-related decline in insulin secretion is partly due to reduced proinsulin processing.
Area of Science:
- Endocrinology
- Metabolic Research
- Aging Biology
Background:
- Beta-cell function is crucial for glucose homeostasis.
- Age-related changes in beta-cell function and insulin processing are not fully understood.
- Proinsulin conversion to insulin is a key step in insulin secretion.
Purpose of the Study:
- To investigate the relationship between aging, beta-cell function, and proinsulin conversion to insulin.
- To determine if impaired proinsulin processing contributes to age-related decline in insulin secretion.
Main Methods:
- Studied insulin and proinsulin secretion in nondiabetic subjects using oral glucose tolerance tests (OGTT) and hyperglycemic clamps.
- Assessed proinsulin to insulin (PI/I) ratios to evaluate conversion efficiency.
- Analyzed correlations between age, beta-cell function indexes, and PI/I ratios.
Main Results:
- A negative correlation was found between age and beta-cell function.
- A positive correlation was observed between age and the PI/I ratio, indicating poorer proinsulin conversion.
- Impaired proinsulin conversion was inversely correlated with first-phase insulin secretion.
- Adjusting for PI/I ratio abolished the age-related decline in first-phase insulin secretion.
Conclusions:
- Aging is associated with reduced beta-cell function and impaired proinsulin conversion to insulin.
- The decline in insulin secretion with age is, in part, attributable to diminished proinsulin processing.
- These findings highlight a novel mechanism for age-related metabolic changes.
More Related Videos
Related Concept Videos
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.